Julien Blouin

Stock Analyst at Goldman Sachs

(3.42)
# 977
Out of 5,138 analysts
27
Total ratings
60%
Success rate
4.19%
Average return

Stocks Rated by Julien Blouin

Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $17.55
Upside: -3.13%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $354.01
Upside: +14.97%
UDR, Inc.
Nov 4, 2025
Maintains: Sell
Price Target: $37$33
Current: $37.08
Upside: -11.00%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $108.35
Upside: -2.17%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $31.72
Upside: +16.65%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $17.07
Upside: +17.16%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $30.54
Upside: +3.14%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $27.06
Upside: +58.91%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $17.52
Upside: -2.97%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $147.49
Upside: -1.69%
Initiates: Buy
Price Target: $176
Current: $170.83
Upside: +3.03%
Initiates: Neutral
Price Target: $318
Current: $253.52
Upside: +25.43%
Initiates: Neutral
Price Target: $81
Current: $61.17
Upside: +32.42%
Initiates: Buy
Price Target: $187
Current: $135.44
Upside: +38.07%